Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Nxplw Drops On Earnings Concerns 20260403 1 DTSS Datasea plunges 585 after Q2 loss widens missing estimates by 716 SIBN SIBONE quarterly loss narrows sharply beating estimates by 689 despite stock decline Stantec beats Q4 estimates by 19 but STN slides 15 as growth outlook disappoints FFIN First beats Q1 earnings estimates by 38 percent yet shares fall 2 percent on cautious outlook BCGWW BinahCapital warrants draw investor interest as quarterly earnings data remains limited amid opaque financial disclosures AI Stocks Surge as Trump Expands Tech Strategy Abroad Sparking IPO Wave Kevin Warsh Secures Senate Confirmation as Next Federal Reserve Chair in Historic Vote Nathans Famous NATH Steady at 10121 Awaiting Next Catalyst 20260517 Interactive IBKR Slips 121 Testing 8285 Support 20260515 AutoZone Stock Plunges in FourYear Worst Session Despite Earnings Beat Shein Acquires Everlane Fast Fashion Giant Takes Over Ethical Luxury Brand Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement Michael Saylor Tokenization Could Create a Free Market in Credit and Yield Challenging Traditional Banking JW Therapeutics CEO China Pharma Sector Unaffected by Beijings Tech Deal Scrutiny Iran Never Bow Vow and Trump Counteroffer Rejection Intensify Middle East Tensions Raising Oil Supply Risks RMR Q1 2026 Earnings EPS Misses Estimates but Stock Steadies ROIV Q1 2026 Earnings Missed Estimates as Pipeline Progress Takes Center Stage Genie Energy Ltd GNE Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher UAL Q1 2026 Earnings EPS Beat Drives Stock Rally Amid Operational Discipline DKS Q1 2026 Earnings Strong Earnings Beat Drives Stock Higher Definium Therapeutics DFTX Slips 066 as Shares Test Key Support Zone KLX Energy Services KLXE Declines 327 Tests Key Support Near 284 Generac GNRC Surges Over 9 as Renewed Demand Optimism Drives Powerful Rally XORTX Therapeutics XRTX Gains 127 as Shares Test Key Resistance Level